DEFENDOR: A Multicenter Prospective Observational Post-registration stuDy of Extimia® (INN: empEgfilrastim) to Evaluate Efficacy and saFEty in patieNts With soliD tumORs

Clinical trial NCT04811443 · UNKNOWN

Trial details

NCT number: NCT04811443
Sponsor: Biocad
Status: UNKNOWN
Study type: OBSERVATIONAL

Patients With Solid Tumours Who Receive Myelosupressive Therapy

Start date: 2021-01-12
Primary completion: 2022-06-12
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.